Countries differ widely in the types of human biotechnologies they regulate,
the jurisdiction of authority, the nature of enforcement, and other
particulars. One requirement for effective policy is a government agency
responsible for licensing and monitoring research and commercial facilities
that work with human embryos. Frequently cited models are Canada's Assisted Human Reproduction Act and the United Kingdom’s
Human Fertilization and Embryology Authority (HFEA).